Uncategorized
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 4, 2019, at 3:35 p.m. EDT in Boston, MA. A live audio webcast for this event will be available in the Investors section of the Glaukos webs